ライフサイエンスコーパス: will be necessary to

1 ablers of sustainable financing, governance, and leadership will be necessary to achieve access while preventing excess a

2 Strong partnerships and political support and will be necessary to achieve these goals.

3 patient population, and further adaptation of the treatment will be necessary to address the unmet needs of patients with

4 Further, such comprehensive energetic characterization will be necessary to benchmark the algorithms required to rat

5 rove the efficacy of microelectronic retinal prosthetics it will be necessary to better understand the response of retina

6 ments and increased efforts from industry and civil society will be necessary to break these vicious cycles.

7 Additional studies will be necessary to characterize the predictors of cognitive

8 Although a large-scale study will be necessary to confirm clinical significance, the set o

9 nough for malaria elimination but rather additional efforts will be necessary to control the disease.

10 normalize pH and carbon dioxide levels, but further studies will be necessary to demonstrate benefit with this technology

11 a population isolate like Finland, and larger sample sizes will be necessary to detect risk variants.

12 Specific validation studies will be necessary to determine the best combination of imagin

13 Continued student tracking will be necessary to determine the long-term program effect.

14 Further larger studies will be necessary to determine whether specific compositional

15 Longer follow up will be necessary to determine whether there is any effect on

16 Further studies will be necessary to determine which patients may benefit fro

17 ral basis for how the brain tells time and operates in time will be necessary to develop general models of cognition.

18 progress from the laboratory to commercial applications, it will be necessary to develop industrially scalable methods to

19 dditional research into the pathophysiology of this disease will be necessary to develop newer, more targeted therapeutic

20 ploit the potential of CAM crops and CAM bioengineering, it will be necessary to elucidate the evolution, genomic feature

21 is fundamental to management and conservation efforts, and will be necessary to ensure future plans and adaptation strat

22 nd allow immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals.

23 Further validation in cell culture and mouse models will be necessary to establish causality for these genes.

24 Trial continuation and additional randomised evidence will be necessary to establish the supposed superior efficacy

25 Further experiments will be necessary to evaluate the efficiency and safety of th

26 ith stereopsis, visual field expansion, and quality of life will be necessary to fully evaluate the role that improved Bi

27 Longer follow-up will be necessary to fully evaluate treatment differences.

28 n of numerous unbiased genome-wide and proteomic approaches will be necessary to fully understand the neuroepigenome and

29 n of, such devastating surface reactions on both electrodes will be necessary to help realize the potential of high-capac

30 Understanding of these fundamental molecular events will be necessary to identify novel host targets, such as FAK

31 r complications although elucidation of downstream pathways will be necessary to identify targets that do not promote nep

32 To fully understand behavioral evolution, it will be necessary to identify the genetic mechanisms that med

33 Ultimately, it will be necessary to identify those patients for whom the str

34 further development, including incorporation of ontologies, will be necessary to improve the performance of the extractio

35 roperties, but also their surrounding surface topographies, will be necessary to improve the yield of single quantum dot

36 prioritisation and innovative solutions to the blood crisis will be necessary to improve this situation and will require

37 Going forward, well-defined policy direction will be necessary to institutionalize ecosystem services appr

38 ht-energy harvesting, CO2 fixation, and carbon partitioning will be necessary to make major headway toward improving phot

39 y propagated species, optimization of aquaculture practices will be necessary to maximize food production and minimize ec

40 hildren in conflict-affected and security-compromised areas will be necessary to prevent reintroduction of WPV into other

41 It will be necessary to prioritize drugs that affect key driver

42 To achieve these benefits, it will be necessary to reduce CO2 sourcing and transport burden

43 t of hypoxia, further nutrient reductions in the Baltic Sea will be necessary to reduce the ecosystems impacts of deoxyge

44 To identify HSCs from in vitro sources, it will be necessary to refine markers of HSCs matured ex vivo.

45 As more RGENs become available, it will be necessary to refine their activity before they can be

46 Future refinement of biomarkers will be necessary to subclassify this group and determine the

47 Furthermore, targeting specific cell types will be necessary to understand how regeneration of the diver

48 hophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find ef

49 h improvements in pulse parameters and X-ray area detectors will be necessary to unlock this potential.

50 Prospective clinical trials with c-Met inhibitors will be necessary to validate MET exon 14 mutations as an imp